Europe midday: Stoxx +1% as banks rip ~4% on Dem Congress, Novo +4% on Wegovy pill beat, defence lags
Posted: Wed Nov 04, 2026 11:04 am
Quick London desk read at lunch.
Stoxx 600 is up roughly 0.6–1% after an ugly overnight futures dip (-1.4% at the lows) that reversed once the Democrats' Senate + House control was clear and the White House accepted the result.
What's moving:
- Banks are the leader — Euro Stoxx banks about +4%, Italy/Spain bank-heavy indices +1.5–2%. Narrative is less US leverage over European lenders plus a faster Iran resolution / lower rates story.
- Clean energy squeeze: Orsted ~+6–7%, Nordex ~+5%, Vestas ~+4%.
- Defence is the drag: BAE about -4%, Rheinmetall/Saab/Thales -2–3.5%.
- Novo Nordisk +3–6% — Q3 beat on Wegovy pill sales, FY sales/EBIT growth guide lifted to -2%/+2% CER (was -6%/flat).
- Earnings pops: Heidelberg Materials ~+9%, Pandora ~+8%, Continental +5–7% on a better 2026 margin outlook. DSM-Firmenich -7.5% (raise already priced in).
- AI power/equipment names soft despite AMD: Siemens Energy -2.7%, Schneider -1%.
For US scalpers: the cross-asset tell is rotation (banks/renewables up, defence/AI-infrastructure down) rather than a straight risk-on. I'd watch whether that carries into XLF / TAN / ITA at the US open.
Sources: [Reuters via Euronext](https://live.euronext.com/en/financial- ... isk-surges), [CNBC on Novo](https://www.cnbc.com/2026/11/04/novo-q3 ... sales.html)
Anyone trading the US renewables gap (FSLR/PLUG/RUN) off this, or fading it? And does the defence weakness show up in LMT/NOC premarket for you?
Stoxx 600 is up roughly 0.6–1% after an ugly overnight futures dip (-1.4% at the lows) that reversed once the Democrats' Senate + House control was clear and the White House accepted the result.
What's moving:
- Banks are the leader — Euro Stoxx banks about +4%, Italy/Spain bank-heavy indices +1.5–2%. Narrative is less US leverage over European lenders plus a faster Iran resolution / lower rates story.
- Clean energy squeeze: Orsted ~+6–7%, Nordex ~+5%, Vestas ~+4%.
- Defence is the drag: BAE about -4%, Rheinmetall/Saab/Thales -2–3.5%.
- Novo Nordisk +3–6% — Q3 beat on Wegovy pill sales, FY sales/EBIT growth guide lifted to -2%/+2% CER (was -6%/flat).
- Earnings pops: Heidelberg Materials ~+9%, Pandora ~+8%, Continental +5–7% on a better 2026 margin outlook. DSM-Firmenich -7.5% (raise already priced in).
- AI power/equipment names soft despite AMD: Siemens Energy -2.7%, Schneider -1%.
For US scalpers: the cross-asset tell is rotation (banks/renewables up, defence/AI-infrastructure down) rather than a straight risk-on. I'd watch whether that carries into XLF / TAN / ITA at the US open.
Sources: [Reuters via Euronext](https://live.euronext.com/en/financial- ... isk-surges), [CNBC on Novo](https://www.cnbc.com/2026/11/04/novo-q3 ... sales.html)
Anyone trading the US renewables gap (FSLR/PLUG/RUN) off this, or fading it? And does the defence weakness show up in LMT/NOC premarket for you?